EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature

Martina Bradová iD, Elaheh Mosaieby, Michael Michal, Tomáš Vaněček, Stanislav Kormunda Ing, Petr Grossmann, Olena Koshyk, Zdeněk Kinkor, Šimon Laciok, Antónia Nemcová, Ľubomír Straka, Mihaela Farkas und 2 weitere

Histopathology · 2024

DOI: 10.1111/his.15121 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Histopathology, 2024. Verfasst von Martina Bradová und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine in Plzen, Charles University, Prague, Czech Republic. Hauptthemen laut MEDLINE: Transcription Factors, Rhabdomyosarcoma. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Spindle‐cell/sclerosing rhabdomyosarcomas (SS‐RMS) are clinically and genetically heterogeneous. They include three well‐defined molecular subtypes, of which those with EWSR1/FUS::TFCP2 rearrangements were described only recently. This study aimed to evaluate five new cases of SS‐RMS and to perform a clinicopathological and statistical analysis of all TFCP2 ‐rearranged SS‐RMS described in the English literature to more comprehensively characterize this rare tumour type. Methods and Results Cases were retrospectively selected and studied by immunohistochemistry, fluorescence in situ hybridization with EWSR1 / FUS and TFCP2 break‐apart probes, next‐generation sequencing (Archer FusionPlex Sarcoma kit and TruSight RNA Pan‐Cancer Panel). The PubMed database was searched for relevant peer‐reviewed English reports. Five cases of SS‐RMS were found. Three cases were TFCP2 rearranged SS‐RMS, having FUSex6::TFCP2ex2 gene fusion in two cases and triple gene fusion EWSR1ex5::TFCP2ex2 , VAX2ex2::ALKex2 and VAX2intron2::ALKex2 in one case. Two cases showed rhabdomyoblastic differentiation and spindle‐round cell/sclerosing morphology, but were characterized by novel genetic fusions including EWSR1ex8::ZBTB41ex7 and PLOD2ex8::RBM6ex7 , respectively. In the statistical analysis of all published cases, CDKN2A or ALK alterations, the use of standard chemotherapy and age at presentation in the range of 18–24 years were negatively correlated to overall survival.

Conclusion

EWSR1/FUS::TFCP2 ‐rearranged SS‐RMS is a rare rhabdomyosarcoma subtype, affecting predominantly young adults with average age at presentation 34 years (median 29.5 years; age range 7–86 years), with a predilection for craniofacial bones, rapid clinical course with frequent bone and lung metastases, and poor prognosis (3‐year overall survival rate 28%).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsRhabdomyosarcomaYoung AdultChildHumansAdultAdolescentMiddle AgedAgedAged, 80 and overIn Situ Hybridization, FluorescenceRetrospective StudiesRNA-Binding Protein EWSGene FusionBiomarkers, TumorRNA-Binding ProteinsProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseDNA-Binding Proteins

Stichwörter der Autor:innen

ALKCDKN2A/BEWSR1FUSMyoD1PLOD2RBM6TFCP2ZBTB41epithelioidintraosseousmolecular geneticsrhabdomyosarcomaspindle cell

Substanzen

Transcription FactorsRNA-Binding Protein EWSBiomarkers, TumorRBM6 protein, humanRNA-Binding ProteinsPLOD2 protein, humanProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseEWSR1 protein, humanTFCP2 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Pathology, Faculty of Medicine in Plzen, Charles University, Prague, Czech Republic.
  • Bioptic Laboratory Ltd, Plzen, Czech Republic.
  • Division of Information Technologies and Statistics, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
  • Medical Laboratory CSD, Kyiv, Ukraine.
  • Department of Pathology, Třinec Hospital, Třinec, Czech Republic.
  • Medicyt Ltd, Košice, Slovakia.

ORCID-Profile: Martina Bradová

Zitieren

APA

Bradová, M., Mosaieby, E., Michal, M., Vaněček, T., Ing, S. K., Grossmann, P., Koshyk, O., Kinkor, Z., Laciok, Š., Nemcová, A., Straka, Ľ., Farkas, M., Michal, M., & Švajdler, M. (2024). Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature. Histopathology. https://doi.org/10.1111/his.15121

Vancouver

Bradová M, Mosaieby E, Michal M, Vaněček T, Ing SK, Grossmann P, et al. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature. Histopathology. 2024. doi:10.1111/his.15121

BibTeX
@article{Bradov2024,
  author = {Bradová, Martina and Mosaieby, Elaheh and Michal, Michael and Vaněček, Tomáš and Ing, Stanislav Kormunda and Grossmann, Petr and Koshyk, Olena and Kinkor, Zdeněk and Laciok, Šimon and Nemcová, Antónia and Straka, Ľubomír and Farkas, Mihaela and Michal, Michal and Švajdler, Marián},
  title = {Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature},
  journal = {Histopathology},
  year = {2024},
  doi = {10.1111/his.15121}
}
Kostenlos starten →